http://orcid.org/0000-0003-4370-0544
References
- Sanaei-Zadeh H, Zamani N, Shadnia S. Outcomes of visual disturbances after methanol poisoning. Clin Toxicol (Phila) 2011;49:102–107.
- Hovda KE, Hunderi OH, Rudberg N, et al. Anion and osmolal gaps in the diagnosis of methanol poisoning: clinical study in 28 patients. Intensive Care Med 2004;30:1842–1846.
- Paasma R, Hovda KE, Hassanian-Moghaddan H, et al. Risk factors related to poor outcome after methanol poisoning and the relation between outcome and antidotes – a multicenter study. Clin Toxicol (Phila) 2012;50:823–831.
- Hassanian-Moghaddam H, Pajoumand A, Dadgar SM, Shadnia SH. Prognostic factors in methanol poisoning. Hum Exp Toxicol 2007;26:583–586.
- Sanaei-Zadeh H, Zamani N. A case of optic nerve atrophy with severe disc cupping after methanol poisoning. Korean J Ophthalmol 2011;25:463; author reply 463.
- Sharma R, Marasini S, Sharma AK, et al. Methanol poisoning: ocular and neurological manifestations. Optom Vis Sci 2012;89:178–182.
- Abrishami M, Khalifeh M, Shoayb M. Therapeutic effects of high-dose intravenous prednisolone in methanol-induced toxic optic neuropathy. J Ocul Pharmacol Ther 2011;27:261–263.
- Shukla M, Shikoh I, Saleem A. Intravenous methylprednisolone could salvage vision in methyl alcohol poisoning. Indian J Ophthalmol 2006;54:68–69.
- Pakravan M, Sanjari N. Erythropoietin treatment for methanol optic neuropathy. J Neuroophthalmol 2012;32:325–328.
- Pakravan M, Esfandiari H, Sanjari N, Ghahari E. Erythropoietin as an adjunctive treatment for methanol-induced toxic optic neuropathy. Am J Drug Alcohol Abuse 2016;42:633–639.
- Brines ML, Chezzi P, Keenan S. Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury. Proc Natl Acad Sci 2000;97:10526–10531.
- Modarres M, GhasemiFalavarjani KH, Nazari H, et al. Intravitreal erythropoietin injection for the treatment of non-arteritic anterior ischemic optic neuropathy. Br J Ophthalmol 2011;95:992–995.
- Kashkouli MB, Pakdel F, Sanjari MS, et al. Erythropoietin, a novel treatment for traumatic optic neuropathy. Arch Clin Exp Ophthalmol 2011;249:731–736.
- Lim LA, Frost NA, Powell RJ, Hewson P. Comparison of the ETDRS logMAR, ‘compact reduced logMar’ and Snellen charts in routine clinical practice. Eye (Lond) 2010;24:673–677.
- Bähr LD. Effect of erythropoietin axotomy–induced apoptosis in rat retinal ganglion cells. Invest Ophthalmol Vis Sci 2004;45:1514–1522.
- King CE, Rodger J, Batlet C, et al. Is both neuroprotective and neurogenerative following optic nerve transaction? Exp Neurol 2007;205:48–55.
- Diem R, Molnar F, Beisse F, et al. Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial—study protocol. BMJ Open 2016;6:e010956.
- Sühs KW, Hein K, Sättler MB, et al. A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis. Ann Neurol 2012;72:199–210.
- Hassanian-Moghaddam H, Mirafzal A, Nikfarjam A, et al. Methanol mass poisoning in Iran: role of case finding in outbreak management. J Public Health 2015;37:354–359.